PD-1-mAb Plus Regimen in the First and Second Lines of Advanced and Unresectable Biliary Tract Carcinoma: A Real-World, Multicenter Retrospective Analysis

Overview of attention for article published in Journal of Inflammation Research, October 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 1 X post from an account with 770 followers.

PD-1-mAb plus regimen in the advanced and unresectable BTC | JIR @DovePress #cholangiotwitter #cholangiocarcinoma #bileductcancer #biliarytractcancer https://t.co/39OQU9GGtY

Reply Repost Favourite